HIV-infected Patients Should Start HAART Sooner, Study Suggests

Under current treatment guidelines, highly active antiretroviral therapy should be considered for HIV-infected patients when their CD4+ T-cell counts fall below 350 cells per cubic millimeter (mm3). However, new epidemiological research suggests that patients with HIV may have less risk of dying if they begin HAART sooner.

Read the whole article on Science Daily

More from Science Daily